Phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of the MEK inhibitor RO4987655 (CH4987655) in patients with advanced solid tumors. (Q54454666)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of the MEK inhibitor RO4987655 (CH4987655) in patients with advanced solid tumors. |
scientific article |
Statements
Phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of the MEK inhibitor RO4987655 (CH4987655) in patients with advanced solid tumors. (English)
1 reference
Suzanne Leijen
1 reference
Mark R Middleton
1 reference
Patricia Tresca
1 reference
Veronique Dieras
1 reference
Max E Scheulen
1 reference
Avinash Gupta
1 reference
Vanesa Lopez-Valverde
1 reference
Zhi-Xin Xu
1 reference
Ruediger Rueger
1 reference
Jean J L Tessier
1 reference
Eliezer Shochat
1 reference
Steve Blotner
1 reference
Valerie Meresse Naegelen
1 reference
Jan H M Schellens
1 reference
Wilfried Ernst Erich Eberhardt
1 reference
5 July 2012
1 reference
18
1 reference
4794-4805
1 reference
17
1 reference
Identifiers
1 reference